Colorado Patent of the Month – May 2023
Certa Dose Inc., a medical device company, is focused on reducing dosing errors across the healthcare industry. The accuracy and efficiency of drug administration during emergency or critical care situations is critical, especially for pediatric patients where even a slight dosing error could lead to disastrous consequences. Certa Dose’s approach uses a color confirmation system to give healthcare providers the certainty that they are giving the correct dose of medication, empowering them to deliver medication safely to patients of all ages.
Traditional drug dosage determination is a multi-step process which creates numerous instances where error could be introduced. Determining the dosage is a multi-step mathematical calculation based on the weight of the patient. Once a dosage is determined, the drug administration phase begins, introducing additional potential for error. Certa Dose’s color confirmation system reduces the number of steps and the chance of error in each step.
Certa Dose’s medicine dispensing device includes a series of color-coded zones of varying widths marked on the surface, with each zone corresponding to a predetermined dose of the drug that is correlated to one of the physical characteristics of a patient. The device is marked such that the smallest dose of the drug to be administered corresponds to the first zone proximate to the opening through which the drug is dispensed. This device helps reduce the possibility of errors by simplifying the dosing process, and the device’s design ensures that the correct dose is dispensed.
The Certa Dose device is accompanied by a dosing label that helps medical personnel calculate the correct dose quickly and easily. The label is color-coded and corresponds to each color zone on the device, and each individual zone width corresponds to a drug dose based on one of the physical characteristics of a patient. The label also includes dosage calculations that enable medical personnel to administer the drug without the need for complex mathematical calculations, reducing the possibility of errors. Certa Dose’s device and label can be used with a wide range of medications and in various clinical settings.
Certa Dose’s newly patented medicine dispensing device and dosing label offer a reliable and efficient way to administer medications during emergency and critical care situations. The company’s story begins with a real-life event where a near overdose in the emergency room inspired a simple solution to one of the most challenging problems in medicine. For Dr. Caleb Hernandez, having a 5-year-old girl almost die under his watch because of a dosing error inspired him to find a better way. A small error, in calculation or administration, nearly resulted in the delivery of a ten times overdose of medicine. It’s hard to say which step would have introduced the error, so Certa Dose set out to simplify each step, leaving no stone unturned.
Are you developing new technology for an existing application? Did you know your development work could be eligible for the R&D Tax Credit and you can receive up to 14% back on your expenses? Even if your development isn’t successful your work may still qualify for R&D credits (i.e. you don’t need to have a patent to qualify). To find out more, please contact a Swanson Reed R&D Specialist today or check out our free online eligibility test.
Who We Are:
Swanson Reed is one of the U.S.’ largest Specialist R&D tax advisory firms. We manage all facets of the R&D tax credit program, from claim preparation and audit compliance to claim disputes.
Swanson Reed regularly hosts free webinars and provides free IRS CE and CPE credits for CPAs. For more information please visit us at www.swansonreed.com/webinars or contact your usual Swanson Reed representative.
Are you eligible?
Why choose us?
Pass an Audit?
What is the R&D Tax Credit?
The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.
Never miss a deadline again
Stay up to date on IRS processes
Discover R&D in your industry
R&D Tax Credit Preparation Services
Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.
If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.
R&D Tax Credit Audit Advisory Services
creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.
Our Fees
Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/
Choose your state
